With the combination of sophisticated equipment, experienced operators and modern drug therapy, PCI has evolved into an effective non-surgical modality of treatment. The efficacy of PTCA has recently improved by coronary stenting and adjunctive pharmacological therapy, such as aspirin 5, 6, 7 , clopidogrel 8.9 and glycoprotein IIb/IIIa receptor blocker 10 . The outcomes of PCI are measured in term of success and complications and related to the mechanism of the employed procedure. The aim of the study was to evaluate the immediate (short-term) clinical and angiographic outcome following PTCA and stenting in patients with coronary artery disease. (CAD).
Methods: Study Patients
Between July' 2004 to October' 2006, 100 consecutive patients underwent PCI at University Cardiac Center (UCC), Banghabandhu Sheikh Mujib Medical University, Dhaka. The study group of patients consisted of 88 (88%) men and 12 (12%) women. With mean age of the patients was 52.4±6.2 years. (Table-01 ). Clinical inclusion criteria were symptomatic coronary artery disease with angina class I to IV and potential indication for coronary artery bypass surgery.
Stenting procedure
PTCA was done by technique as described by Gruentzig through femoral arterial approach according to modified seldinger technique. Outer diameter of guiding catheter was 7 to 8 French and 0.014 J steerable guidewire were used and dilatation was attempted using balloon catheter with 20-30 x 2-3 mm balloon size and balloon mounted stents were implanted at the target site. The balloon inflation pressure ranged from 4 to 14 atmosphere. Predilatation was performed using undersized, conventional angioplasty balloon before stenting.
Stenting was not performed in a vessel with a diameter 2.5 mm, if the lesion was longer than 40 mm, in case of extreme vessel tortuousity, if a large thrombus was visible at lesion site.
Medications, sheath removal and discharge
All patients received aspirin (75 mg daily) indefinitely and clopidogrel (75 mg daily) 72 hours before the procedure up to six month to one year after procedure. Intravenous heparin 10,000 unit IV was given as bolus during procedure and APTT was monitored. Sheath was removed after 4-6 hours and uncomplicated patients were discharged on next day.
Outcome:
The outcome of PCl are measured interms of success and complication and are related to the mechanism of the deployed devices as well as the clinical and anatomical patient-related factors. Complications can be divided into two categories;
Those common to all arterial catheterization procedures and Those related to the specific technology used for the coronary procedure. With increased operator experience, new technology and adjunctive pharmacotherapy, the overall success and complication rate of angioplasty have improved.
Definitions of PCI Success:
The success of a PCI procedure may have the following components-angiographic success, procedural success and clinical success.
Angiographic success-A successful PCI produces substantial enlargement of the lumen at the target site. Previously defination was the achievement of a minimum stenosis diameter reduction to <50% in the presence of grade 3 TIMI flow 11 . With the advent of advanced adjunct technology, including coronary stents, a minimum stenosis diameter reduction to <20% has been the bench mark of an optimal angiographic result.
Procedural success-A successful PCI should achieve angiographic success without in hospital major clinical complications eg. death, myocardial infarction, emergency coronary artery bypass surgery during hospitalization 11, 12 .
Clinical success-clinically successful PCI includes anatomic and procedural success with relief of signs and or symptoms of myocardial ichaemia after the patient recovers from the procedure 13, 14 .
Definitions of procedural complications. According to the 1998 coronary interventional document 13 procedural complications are dovided into six basic categories: death, MI, emergency CABG, stroke, vascular access site complications and contrast agent nephropathy.
Results:
In this study 36 (36%) patients had history of hypertension, 30 (30%) were smokers, 20 (20%) were diabetic, 14 (14%) had family history of ischaemic heart disease. Average left ventricular ejection fraction (LVEF) was 54.2 ± 7 ( Table-I ). Among these cases coronary vessel involved in 147 cases, target vessels were 130, PTCA was done in 124 and intracoronary stent deployed in 124 patients ( Table-II) .
Most of the patients in study presented as a case of post MI angina (38%) followed by stable angina pectoris (18%) ( Table-I) Single vessel disease was 60 (60%), double vessel disease was 33 (33%). triple vessel disease was 7 (7%). (Table-II) . Majority of the patient had Type A Lesion 81 (62.3%). 93 (93%) patients had clinical success, 95 (95%) patient had angiographic and procedural success (Table-VI).
All the stent implantation procedures were successful except 1 five. In particular, there was one stent displacement. Intracoronary stent implanted in LAD 71 (57.3%), (Fig 1.a. (Fig-2, a,b) . Diagonal 10 (8.07%) and Marginal 3 (2.4%) ( Table-03 ). Failed PTCA were in five cases due to tortuousity of vessels or total occlusion not crossed by PTCA wire or balloon. Bere metal stents (BMS) were deployed in most of the patient (71.8%) ( Table-IV) . with mean diameters (mm) 2.89+02 and mean leangth of 14.68 mm+2. TIMI Grade 03 flow was in 91 patients (70%) ( Table  -V) . Three patients developed coronary artery dissection during the procedures who needed immediate intracoronary stent deployment. Stentangioplasty were successfully done in 12 patients with CTO and failed in 3 (three) patient due to failure in crossing guide wire. Three patients developed ischaemic pain and two patients developed heart failure and six patients developed major arrhythmias ( Table-VII) . 
Discussion:
Based on our result, we believe that all types of PTCA and intracoronary stenting can play an important role in the treatment of symptomatic coronary artery diseases. Our in hospital mortality rate was one (%) comparing favorably with the results obtained in the previous angioplasty trials 15, 16, 17 . The mean age of our study population was 52.4 ± 6.2 years, which is earlier age than other studies 16, 18. Early recurrent ischaemia occurred in 4 (4%) patients in our series. Grines LC et al and Moreno R et al showed early recurrent ischaemia after PTCA in 5.1% and 6.5%, cases in their series 15, 18 , which are very close to our study and other studies in our country 13, 14 . Chest pain without changes on ECG just after PTCA occurred in cases which simulate the results of other study 15 .
Two patients had reappearance of symptoms within 1 month. Check angiogram of them were done which showed normal functioning of the stents. Thrombus containing lesions have been considered as contraindication for stentangioplasty. Stents were successfully deployed in two patients containing thrombus in LAD (Proximal) and LCX (distal) after treatment with low molecular weight heparin. Studies have shown that presence of angiographicaly visible thrombus as a risk factor for subsequent stent thrombosis 16 . However, other have represented coronary stenting as safe and effective therapy for thrombus containing lesion 17, 18 . Percutaneous intervention (PCI) of the chronic total occlusion (CTO) lesion present great challenge including reduced success rate, prolonged procedure time, large amount of contrast use, high occlusion rate, and costs. The goal of intervention in CTO is to penetrate the total occlusion and pass the wire in the true luman of the distal vessel without causing stent angioplasty intimal dissection, Accordingly we have successfully done stentangioplasty in 12 patients with CTO and failed in three patient due to failure of passing the wire.
Limitation of the Study:
This is single center observational prospective study to assess the safety and short-term clinical and angiographic outcome of small number of patients. Further randomized trial may be needed for the better result.
Conclusion:
Percutaneous coronary intervention (PCI) have revolutionized the effective management of coronary artery disease and their symptoms. It has been increasingly demonstrated to reduce the risk of adverse events in patients with acute coronary syndrome (ACS). Intracoronary stent implantation in coronary artery stenosis following PTCA is a valid strategy with good clinical and angiographic inhospital results. This very study is an initial experience in a new center with small number of patients may serve as an impetus for future large scale study in home and abroad.
